Skip to content

BEET PAH: a Study to Assess the Effects of Beetroot Juice in Patients With Pulmonary Arterial Hypertension

BEET PAH: a Study to Assess the Effects of Beetroot Juice in Patients With Pulmonary Arterial Hypertension

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02000856
Acronym
BEET-PAH
Enrollment
15
Registered
2013-12-04
Start date
2013-11-30
Completion date
2015-02-28
Last updated
2018-03-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pulmonary Arterial Hypertension

Brief summary

The study is a single center randomised, double-blind, placebo-controlled crossover study to assess the effects of beetroot juice in patients with pulmonary arterial hypertension.

Interventions

DIETARY_SUPPLEMENTBeetroot juice

Sponsors

Karolinska Institutet
CollaboratorOTHER
Uppsala University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* PAH (pulmonary arterial hypertension) * WHO functional class II-III

Exclusion criteria

* WHO functional class I or IV * pregnancy * known intolerance or allergy to beetroot * treatment with Allopurinol * treatment with Iloprost (inhaled) * systolic bloodpressure \< 95 mmHg * diabetes mellitus type 2

Design outcomes

Primary

MeasureTime frame
Change in VO2 submax and or VO2 max7 days

Secondary

MeasureTime frameDescription
Change in WHO functional class7 days
Change in echocardiographic parameters7 daysChange in; pulmonary artery systolic pressure (PASP), ventricular diastolic function, systolic right and left ventricular function, right and left atrial/ventricular dimensions will be calculated
Change in exhaled NO7 days
Change in 6MWT7 days
Change in metabolic pathways involved in nitric oxide production and regulation7 daysChange in the following biochemical variables will be calculated; ADMA, SDMA, Arginine, Citrulline, Ornithine, uric acid, nitrate, nitrite
Change in NT-pro-BNP7 days
Change in systemic bloodpressure7 days

Countries

Sweden

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026